Amanote Research

Amanote Research

    RegisterSign In

Emerging New Pathways of Pathogenesis and Targets for Treatment in Systemic Lupus Erythematosus and Sjogrenʼs Syndrome

Current Opinion in Rheumatology - United States
doi 10.1097/bor.0b013e32832efe6b
Full Text
Open PDF
Abstract

Available in full text

Categories
Rheumatology
Date

September 1, 2009

Authors
Andras Perl
Publisher

Ovid Technologies (Wolters Kluwer Health)


Related search

Systemic Lupus Erythematosus and Antiphospholipid Syndrome

Frontiers Research Topics
2019English

Self-dsDNA in the Pathogenesis of Systemic Lupus Erythematosus

Clinical and Experimental Immunology
AllergyImmunology
2017English

Pathogenesis of Neuropsychiatric Syndromes of Systemic Lupus Erythematosus

Open Journal of Rheumatology and Autoimmune Diseases
2015English

Immunometabolic Disorders in the Pathogenesis of Systemic Lupus Erythematosus

Postepy Dermatologii I Alergologii
DermatologyAllergyImmunology
2019English

Pathogenesis of Human Systemic Lupus Erythematosus: Recent Advances

Trends in Molecular Medicine
Molecular MedicineMolecular Biology
2010English

Treatment Satisfaction in Systemic Lupus Erythematosus

Journal of Clinical Rheumatology
MedicineRheumatology
2017English

Steroid Treatment of Systemic Lupus Erythematosus

Ensho
1982English

Integral Treatment of Systemic Lupus Erythematosus

2011English

Features, Treatment and Outcomes of Macrophage Activation Syndrome in Childhood-Onset Systemic Lupus Erythematosus

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy